Feenstra, Minke L.
Alkemade, Lily
van den Bergh, Janneke E.
Gisbertz, Suzanne S.
Daams, Freek
van Berge Henegouwen, Mark I.
Eshuis, Wietse J.
Article History
Received: 12 May 2022
Accepted: 22 August 2022
First Online: 10 October 2022
Disclosures
: Mark van Berge Henegouwen has is a consultant for Mylan, Alesi, Johnson and Johnson, Medtronic, and BBraun. All fees are paid to the institution and unrelated to current study. He also has a Stryker grant, with the fee paid to the institution and unrelated to current study. The remaining authors have no conflicts of interest.